Structural basis for TIR domain-mediated innate immune signaling by Toll-like receptor adaptors TRIF and TRAM
- PMID: 39786929
- PMCID: PMC11745336
- DOI: 10.1073/pnas.2418988122
Structural basis for TIR domain-mediated innate immune signaling by Toll-like receptor adaptors TRIF and TRAM
Erratum in
-
Correction for Manik et al., Structural basis for TIR domain-mediated innate immune signaling by Toll-like receptor adaptors TRIF and TRAM.Proc Natl Acad Sci U S A. 2025 Mar 11;122(10):e2502122122. doi: 10.1073/pnas.2502122122. Epub 2025 Feb 20. Proc Natl Acad Sci U S A. 2025. PMID: 39977331 Free PMC article. No abstract available.
Abstract
Innate immunity relies on Toll-like receptors (TLRs) to detect pathogen-associated molecular patterns. The TIR (Toll/interleukin-1 receptor) domain-containing TLR adaptors TRIF (TIR domain-containing adaptor-inducing interferon-β) and TRAM (TRIF-related adaptor molecule) are essential for MyD88-independent TLR signaling. However, the structural basis of TRIF and TRAM TIR domain-based signaling remains unclear. Here, we present cryo-EM structures of filaments formed by TRIF and TRAM TIR domains at resolutions of 3.3 Å and 5.6 Å, respectively. Both structures reveal two-stranded parallel helical arrangements. Functional studies underscore the importance of intrastrand interactions, mediated by the BB-loop, and interstrand interactions in TLR4-mediated signaling. We also report the crystal structure of the monomeric TRAM TIR domain bearing the BB loop mutation C117H, which reveals conformational differences consistent with its inactivity. Our findings suggest a unified signaling mechanism by the TIR domains of the four signaling TLR adaptors MyD88, MAL, TRIF, and TRAM and reveal potential therapeutic targets for immunity-related disorders.
Keywords: MyD88-independent TLR signaling; TIR domain; cryo-EM; helical reconstruction.
Conflict of interest statement
Competing interests statement:The authors declare no competing interest.
Figures
References
-
- Medzhitov R., et al. , Innate immunity. N. Engl. J. Med. 343, 338–344 (2000). - PubMed
-
- Akira S., et al. , Pathogen recognition and innate immunity. Cell 124, 783–801 (2006). - PubMed
-
- Oshiumi H., et al. , TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4, 161–167 (2003). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
